Description of Collaborative Activity: |
The 21st Century Cures Act, passed in December 2016, establishes a Regenerative Medicine Innovation Project (RMIP) to accelerate the field by supporting clinical research on adult stem cells while promoting the highest standards for carrying out scientific research and protecting patient safety. In recognition of the integral role of the Food and Drug Administration (FDA) in the successful development of this field, NIH is leading the RMIP in coordination FDA. |
NIH Participating Institutes/Centers/Office of the Director: |
NCATS, NEI, NHLBI, NIA, NIAID, NIAMS, NIBIB, NIDCD, NIDCR, NIDDK, NIMH, NINDS |
